157 related articles for article (PubMed ID: 28857434)
1. Self-consciousness/awareness and bladder sensations: Comparative study of overactive bladder patients and healthy volunteers.
Vrijens D; Marcelissen T; Drossaerts J; Heeringa R; Degaillier S; Leue C; van Koeveringe G
Low Urin Tract Symptoms; 2019 Jan; 11(1):3-7. PubMed ID: 28857434
[TBL] [Abstract][Full Text] [Related]
2. Bladder sensations in male and female overactive bladder patients compared to healthy volunteers: a sensation-related bladder diary evaluation.
Herrewegh AGM; Vrijens DMJ; Marcelissen TAT; van Koeveringe GA
Scand J Urol; 2019 Aug; 53(4):255-260. PubMed ID: 31354017
[No Abstract] [Full Text] [Related]
3. The multidimensional sensation of desire to void differs between people with and without overactive bladder.
Das R; Buckley JD; Williams MT
Neurourol Urodyn; 2015 Jun; 34(5):444-9. PubMed ID: 24664952
[TBL] [Abstract][Full Text] [Related]
4. Do patients with OAB experience bladder sensations in the same way as healthy volunteers? A focus group investigation.
Heeringa R; van Koeveringe GA; Winkens B; van Kerrebroeck PE; de Wachter SG
Neurourol Urodyn; 2012 Apr; 31(4):521-5. PubMed ID: 22396435
[TBL] [Abstract][Full Text] [Related]
5. Descriptors of sensation confirm the multidimensional nature of desire to void.
Das R; Buckley JD; Williams MT
Neurourol Urodyn; 2015 Feb; 34(2):161-6. PubMed ID: 24249522
[TBL] [Abstract][Full Text] [Related]
6. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
[TBL] [Abstract][Full Text] [Related]
7. Assessing multiple dimensions of urgency sensation: The University of South Australia Urinary Sensation Assessment (USA
Das R; Buckley J; Williams M
Neurourol Urodyn; 2017 Mar; 36(3):667-672. PubMed ID: 26999753
[TBL] [Abstract][Full Text] [Related]
8. Overactive bladder is not only overactive but also hypersensitive.
Lee SR; Kim HJ; Kim A; Kim JH
Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of urodynamic filling sensation at weekly interval in healthy volunteers and in women with detrusor overactivity.
Van Meel TD; Wyndaele JJ
Neurourol Urodyn; 2011 Nov; 30(8):1586-90. PubMed ID: 21538500
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
[TBL] [Abstract][Full Text] [Related]
11. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
12. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
13. Severe depression and anxiety in women with overactive bladder.
Melotti IGR; Juliato CRT; Tanaka M; Riccetto CLZ
Neurourol Urodyn; 2018 Jan; 37(1):223-228. PubMed ID: 28407347
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
15. Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life.
Reisch R; Rutt R; Dockter M; Sanders S
J Womens Health (Larchmt); 2018 Feb; 27(2):156-161. PubMed ID: 28953429
[TBL] [Abstract][Full Text] [Related]
16. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
17. Defining overactive bladder as hypersensitivity.
Yamaguchi O; Honda K; Nomiya M; Shishido K; Kakizaki H; Tanaka H; Yamanishi T; Homma Y; Takeda M; Araki I; Obara K; Nishizawa O; Igawa Y; Goto M; Yokoyama O; Seki N; Takei M; Yoshida M
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):904-7. PubMed ID: 17663416
[TBL] [Abstract][Full Text] [Related]
18. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity?
Fan YH; Lin CC; Lin AT; Chen KK
J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137
[TBL] [Abstract][Full Text] [Related]
19. Screening for depression and anxiety in patients with storage or voiding dysfunction: A retrospective cohort study predicting outcome of sacral neuromodulation.
Drossaerts J; Vrijens D; Leue C; Schilders I; Van Kerrebroeck P; van Koeveringe G
Neurourol Urodyn; 2016 Nov; 35(8):1011-1016. PubMed ID: 26351817
[TBL] [Abstract][Full Text] [Related]
20. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women.
Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T
Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
